Related references
Note: Only part of the references are listed.Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting
Maurilio Ponzoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mutant p53 proteins: Between loss and gain of function
Sabrina Strano et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography
Timothy C. Greiner
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
Drug resistance in diffuse large B-cell lymphoma
Wyndham H. Wilson
SEMINARS IN HEMATOLOGY (2006)
Promoter hypermethylation of the DNA-repair gene O6-Methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma
Junji Hiraga et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Assessing p53 in clinical contexts: unlearned lessons and new perspectives
PA Hall et al.
JOURNAL OF PATHOLOGY (2006)
Analysis of TP53 gene mutations in human lung cancer: Comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing
R Holmila et al.
CANCER DETECTION AND PREVENTION (2006)
The P53 pathway: what questions remain to be explored?
A. J. Levine et al.
CELL DEATH AND DIFFERENTIATION (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation:: Influence of tumor site, type of mutation, and adjuvant treatment
A Russo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
p53 mutation heterogeneity in cancer
T Soussi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
What have animal models taught us about the p53 pathway?
G Lozano et al.
JOURNAL OF PATHOLOGY (2005)
Modelling clustered survival data from multicentre clinical trials
DV Glidden et al.
STATISTICS IN MEDICINE (2004)
Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma.: An analysis of 51 cases and review of the literature
FR Kerbauy et al.
LEUKEMIA & LYMPHOMA (2004)
TP53 in gastric cancer: Mutations in the L3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome
M Migliavacca et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity
MA Resnick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France)
J Breton et al.
MUTAGENESIS (2003)
TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance
S Peller et al.
HUMAN MUTATION (2003)
p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas
K Leroy et al.
ANNALS OF ONCOLOGY (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Physical interaction with human tumor-derived p53 mutants inhibits p63 activities
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor suppressor genes in normal and malignant hematopoiesis
U Krug et al.
ONCOGENE (2002)
Integrating mutation data and structural analysis of the TP53 tumor, suppressor protein
ACR Martin et al.
HUMAN MUTATION (2002)
TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis
M Olivier et al.
SEMINARS IN CANCER BIOLOGY (2001)
Overall survival in aggressive B-Cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27
M Sánchez-Beato et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
